NIH-funded research R01 grant

Mapping how aging changes the molecular switches in T cells

Official title: Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence

Funded at La Jolla Institute for Immunology · NIH-11262912 · Data updated 2026-11-12

Using gene-editing tools to find which molecular switches in CD8 T cells stop working with age, with the goal of helping older adults keep stronger immune responses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLa Jolla Institute for Immunology
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMay 1, 2024
Project endJanuary 31, 2029
Funding year2026
Award (this year)$559,601
NIH project number5R01CA279795-03
Project IDNIH-11262912 on NIH RePORTER

Who could benefit from this research

Could help

People most likely to be involved are older adults or volunteers willing to donate blood samples for T cell studies, especially those with signs of age-related immune decline.

Less likely to help

Young healthy individuals or patients seeking immediate clinical treatments are unlikely to receive direct benefit from this laboratory-focused research.

What this research studies

Researchers will use CRISPR base editors to make precise changes at thousands of phosphorylation sites in T cells and then measure how those changes affect T cell behavior such as activation and killing. They will combine mass spectrometry maps of phosphorylation with high-throughput cell-based screens to link specific molecular changes to declines seen in aging immune cells. Much of the work will be done in laboratory cell systems and likely in donated human T cells to model immunosenescence. The team aims to pinpoint which phosphorylation sites are most important for weakened T cell function in older people so future therapies can target them.

Why it matters

Potential benefit: Could reveal new molecular targets to restore T cell function in older adults, improving vaccine responses and cancer surveillance.

How similar studies have gone: CRISPR screens and base-editing approaches have previously identified important immune regulators, but large-scale functional mapping of phosphorylation sites in aging T cells is largely novel.

Where this research is happening

  • La Jolla Institute for Immunology
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Myers, Samuel Anthony — La Jolla Institute for Immunology
  • Study coordinator: Myers, Samuel Anthony

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.